HyaGuard is our flagship pipeline product to solve the long running issues of excessive post-op #inflammation and #fibrosis in #glaucoma patients. youtu.be/JMBTq5DYYPk

Thanks for the coverage Silicon Republic ! Can't wait for kick off tomorrow! siliconrepublic.com/start-ups/iris…

We're presenting at this year's Ophthalmology Futures European Forum in Vienna, Austria! Looking forward to presenting our sustained release technology for managing post-operative #glaucoma scarring among so many outstanding eye-care companies. 🇮🇪 ophthalmology-futures.com/euro-2023/

Today we finished our 8-week adventure with some fantastic companies on the Pioneer Group accelerator at their state of the art campus in Dublin. A fantastic programme for any start-ups or near start-ups to fine tune their customer discovery! #Innovation #Startup #glaucoma

Happy New Year Everyone! January is #glaucomaawareness month in the USA. Please see below to learn more about one of the most common underlying causes in #glaucoma. youtu.be/XlI_JXYMzbs?si… via YouTube

Delighted to announce finalisation of our pre-seed funding through Enterprise Ireland and the pre-seed start fund! We now have runway to full seed investment and essential #regulatory and #reimbursement work as we look to improve #glaucoma #surgery outcomes. 🚀 🇮🇪

National Gallery makes changes to five famous paintings in new experiment National Gallery has teamed up with Specsavers to alter five of the nation's most famous paintings, to show what they'd look like to someone with #glaucoma mirror.co.uk/news/uk-news/e…

Some recent practice insertions with our HyaGuard inserts using the Eye 4 #Trabeculectomy model thanks to eyecre.at GmbH! HyaGuard™ fits cleanly sub-conj and within the dimensions of a human eye following #glaucoma drainage #surgeries. youtu.be/XlqeXzUHgcc?si…

Latest Industry News & Trends | Market Scope market-scope.com/pages/news/756…

Thanks Eyewire+ for sharing! 🚀🇮🇪 #glaucoma #Ophthalmology #startup #venture eyewire.news/news/lep-biome…

LEP Biomedical announced pre-seed funding of €100,000 ($107,000) over two 6-month periods, which the company says will allow for further preclinical milestones in the development of the HyaGuard platform. bit.ly/3UwXN1s

We're absolutely delighted to be shortlisted! Fantastic to see the broad interest in our mission to ensure outcomes in #glaucoma and #ophthalmic surgeries using our HyaGuard™ controlled #drugdelivery platform. Congrats also to all our fellow shortlisted companies!😁🇮🇪🚀

Pitches of the Innovation Award shortlisted candidates: LEP Biomedical LEP Biomedical is a pre-clinical stage drug-device spinout. Making Glaucoma drainage surgeries 100% successful. #FHSummit24 Investnet

After a good round of networking & lunch, time for the much anticipated list of finalists for Investnet FHS 2024 Innovation Award sponsored by UPMC Ireland Congratulations to @cymanticmedical LEP Biomedical Inthelia Therapeutics 👏👏 Investnet #FHSummit24

We had a super few days at the #FHSummit24 and were delighted to be selected as one of the final 3 for their #Innovation Award. Congrats Cymantic Medical especially to winner Inthelia Therapeutics!

Good morning #EGS2024! Please drop by this morning from 10.30 at P3.021 to see how we aim to address the underlying cause of many failures in #glaucoma drainage surgeries! HyaGuard aims to eliminate the need for MMC and drops to give better outcomes and happier patients!